Patent details

EP2482812 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING BI-1356 AND METFORMIN

Basic Information

Publication number:
EP2482812
PCT Application Number:
EP2010064691
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107603516
PCT Publication Number:
WO2011039367
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITIONS COMPRISING BI-1356 AND METFORMIN
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES CONTENANT LE BI-1356 ET LA METFORMINE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND BI-1356 UND METFORMIN
SPC Number:

Dates

Filing date:
01/10/2010
Grant date:
11/01/2023
EP Publication Date:
08/08/2012
PCT Publication Date:
07/04/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/01/2023
EP B1 Publication Date:
11/01/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/10/2023
Expiration date:
01/10/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/01/2023
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

Name:
MEINICKE, Thomas
Address:
Germany (DE)

Priority

Priority Number:
09172117
Priority Date:
02/10/2009
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/155; A61K 31/522; A61P 3/00; A61K 47/18;

Publication

European Patent Bulletin

1

Issue number:
202302
Publication date:
11/01/2023
Description:
Grant (B1)

2

Issue number:
202307
Publication date:
15/02/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages